{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "PLN", "exchange": "WSE", "shortName": "MOLECURE", "longName": "Molecure S.A.", "messageBoardId": "finmb_263531047", "exchangeTimezoneName": "Europe/Warsaw", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "pl_market", "esgPopulated": false, "regularMarketChangePercent": 2.6315844, "regularMarketPrice": 21.45, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.30470014, "fiftyTwoWeekLow": 12.04, "fiftyTwoWeekHigh": 30.85, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.05, "sharesOutstanding": 14060000, "bookValue": 8.755, "fiftyDayAverage": 22.0964, "fiftyDayAverageChange": -0.64639854, "fiftyDayAverageChangePercent": -0.029253569, "twoHundredDayAverage": 17.0785, "twoHundredDayAverageChange": 4.3715, "twoHundredDayAverageChangePercent": 0.25596508, "marketCap": 312408544, "priceToBook": 2.4500287, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "OncoArendi Therapeutics S.A.", "nameChangeDate": "2023-05-14", "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.55000114, "regularMarketTime": 1684140785, "regularMarketDayHigh": 21.45, "regularMarketDayRange": "20.9 - 21.45", "regularMarketDayLow": 20.9, "regularMarketVolume": 2378, "regularMarketPreviousClose": 20.9, "bid": 21.45, "ask": 21.6, "fullExchangeName": "Warsaw", "financialCurrency": "PLN", "regularMarketOpen": 20.9, "averageDailyVolume3Month": 15359, "averageDailyVolume10Day": 10814, "fiftyTwoWeekLowChange": 9.410001, "fiftyTwoWeekLowChangePercent": 0.78156155, "fiftyTwoWeekRange": "12.04 - 30.85", "fiftyTwoWeekHighChange": -9.4, "firstTradeDateMilliseconds": 1524121200000, "symbol": "MOC.WA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Zwirki i Wigury 101", "city": "Warsaw", "zip": "02-089", "country": "Poland", "phone": "48 225 52 67 24", "website": "https://molecure.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. It is involved in the development of OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has completed phase I clinical trial for the treatment of idiopathic pulmonary fibrosis and sarcoidosis; YKL-40 program for the treatment of cancer and fibrosis; OATD-02, an arginase for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcin Jan Szumowski Ph.D.", "title": "Co-Founder, CEO & Pres of Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Slawomir Piotr Broniarek", "title": "CFO & Member of the Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Adam  Golebiowski Ph.D.", "title": "Co-Founder & VP of Research Chemistry", "fiscalYear": 2017, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jacek  Olczak Ph.D.", "title": "Co-Founder & Head of Medicinal Chemistry", "fiscalYear": 2017, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Zbigniew  Zaslona", "title": "Chief Scientific Officer & Member of Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Agnieszka  Rajczuk-Szczepanska", "title": "Member of Management Board & HR Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Samson  Fung M.D.", "title": "Chief Medical Officer & Member of Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Magdalena  Tyszkiewicz", "title": "Head of CMC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marta  Borkowska", "title": "Director of the Management Board Office", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1514678400, "maxAge": 86400}}], "error": null}}